Eligard kit 22.5mg 3-Month (LEUPROLIDE ACETATE)

Reference priceKRW ₩850,500.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.

Brand	Eligard kit
Manufacturer	ICS TOLMAR PHARMA INC
Prescription required	Yes

Description

Eligard kit 22.5mg 3-Month (LEUPROLIDE ACETATE) is a medicine catalog record in the MediPriceHub database. Active ingredient: LEUPROLIDE ACETATE. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: ICS TOLMAR PHARMA INC. Therapeutic category: Medicine Library > Oncology Medicines > Prostate Cancer Medicines. Pack information: 22.5. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

Leuprolide acetate injection is indicated in the palliative treatment of advanced prostatic cancer.

How to Use

Use LEUPROLIDE ACETATE under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.

Specification

Active ingredient: LEUPROLIDE ACETATE. Pack size: 22.5. Pack unit: unit. Manufacturer: ICS TOLMAR PHARMA INC. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Prostate Cancer Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.

이 정보는 참고용입니다. 의약품 사용 전 의료 전문가와 상담하세요.